Literature DB >> 28500191

Family physicians' role in hidradenitis suppurativa management.

Valerio De Vita1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28500191      PMCID： PMC5429050     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  13 in total

Review 1.  Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa.

Authors:  Iben Marie Miller; Rachel J McAndrew; Iltefat Hamzavi
Journal:  Dermatol Clin       Date:  2016-01       Impact factor: 3.478

2.  Diagnostic delay in hidradenitis suppurativa is a global problem.

Authors:  D M Saunte; J Boer; A Stratigos; J C Szepietowski; I Hamzavi; K H Kim; K Zarchi; C Antoniou; L Matusiak; H W Lim; M Williams; H H Kwon; M A Gürer; F Mammadova; A Kaminsky; E Prens; H H van der Zee; V Bettoli; S Zauli; J Hafner; S Lauchli; L E French; H Riad; M El-Domyati; H Abdel-Wahab; B Kirby; G Kelly; P Calderon; V del Marmol; F Benhadou; J Revuz; C C Zouboulis; I Karagiannidis; K Sartorius; L Hagströmer; E McMeniman; N Ong; M Dolenc-Voljc; Z B Mokos; L Borradori; R E Hunger; C Sladden; N Scheinfeld; N Moftah; L Emtestam; J Lapins; N Doss; I Kurokawa; G B E Jemec
Journal:  Br J Dermatol       Date:  2015-11-03       Impact factor: 9.302

3.  Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa.

Authors:  A L Lima; I Karl; T Giner; H Poppe; M Schmidt; D Presser; M Goebeler; B Bauer
Journal:  Br J Dermatol       Date:  2015-12-12       Impact factor: 9.302

4.  Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study.

Authors:  I C Janse; I E Deckers; A D van der Maten; A W M Evers; J Boer; H H van der Zee; E P Prens; B Horváth
Journal:  Br J Dermatol       Date:  2017-02-24       Impact factor: 9.302

5.  Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.

Authors:  Julia Shlyankevich; Allison J Chen; Grace E Kim; Alexandra B Kimball
Journal:  J Am Acad Dermatol       Date:  2014-10-14       Impact factor: 11.527

6.  Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa.

Authors:  Anargyros Kouris; Eftychia Platsidaki; Christos Christodoulou; Vasiliki Efstathiou; Clio Dessinioti; Vasiliki Tzanetakou; Panagiota Korkoliakou; Chrisa Zisimou; Christina Antoniou; George Kontochristopoulos
Journal:  Dermatology       Date:  2017-01-05       Impact factor: 5.366

Review 7.  What is hidradenitis suppurativa?

Authors:  Erika Yue Lee; Raed Alhusayen; Perla Lansang; Neil Shear; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

8.  Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.

Authors:  Jean E Revuz; Florence Canoui-Poitrine; Pierre Wolkenstein; Cedric Viallette; Germaine Gabison; Florence Pouget; Florence Poli; Ousmane Faye; Jean Claude Roujeau; Genevieve Bonnelye; Jean Jacques Grob; Sylvie Bastuji-Garin
Journal:  J Am Acad Dermatol       Date:  2008-10       Impact factor: 11.527

9.  The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities.

Authors:  V Bettoli; S Pasquinucci; S Caracciolo; D Piccolo; S Cazzaniga; F Fantini; L Binello; G Pintori; L Naldi
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-05-02       Impact factor: 6.166

10.  Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.

Authors:  K Sartorius; L Emtestam; G B E Jemec; J Lapins
Journal:  Br J Dermatol       Date:  2009-04-29       Impact factor: 9.302
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.